Myths and mysteries surrounding bacillus Calmette-Guérin therapy for bladder cancer - Abstract

Intravesical therapy with bacillus Calmette-Guérin has proven effects for reducing recurrence, progression, and death from non-muscle-invasive bladder cancer.

These advantages are seen mainly when appropriate maintenance therapy is used for 1-3 years, in the context of appropriate patient selection, tumor management, and symptom support for potential side effects.

Written by:
Kamat AM, Porten S   Are you the author?

Reference: Eur Urol. 2014 Feb;65(2):267-9 Epub 2013 Oct 26
doi: 10.1016/j.eururo.2013.10.016


PubMed Abstract
PMID: 24199712

UroToday.com Bladder Cancer Section

 

email news signup